Research grants for Czech researchers

Joint Transnational Call (JTC) 2026 — joint transnational call by the BE READY NOW European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

Supports outstanding early-career postdoctoral scientists seeking dual expertise in immunology and data science/immuno-informatics for cancer research.

Open to postdoctoral researchers with a doctoral degree and <5 years of mentored research experience (M.D. applicants exclude residency years). Research must be in immunology or cancer immunology at a non-profit institution worldwide. No citizenship restrictions. Sponsor must hold assistant professor rank or higher. Only 1 fellow per sponsor per round.

For postdoctoral researchers with dual expertise in immunology and data science/computational biology. Applicants must hold a doctoral degree by award activation and have <5 years of mentored research experience (M.D.s exclude residency years). Must be conducted at a non-profit institution (US or abroad); no citizenship restrictions. Stipend $74k–$78k/year over 3 years; host institution receives $5k/year allowance.

Restricted to nationals or long-term residents of EU Member States or Horizon Europe Associated Countries, max 8 years post-PhD. Outgoing phase at a non-EU/non-Associated Country organisation, with mandatory return phase to an EU/Associated Country host. Full-time commitment required; mobility rules apply.

Postdoctoral researchers of any nationality, max 8 years full-time research experience post-PhD at deadline. Mobility rule applies: researcher must not have resided/worked in the host country for >12 months in the 3 years before deadline. Full-time commitment required. Host must be an eligible organisation in an EU Member State or Horizon Europe Associated Country.

Horizon Europe RIA under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €15M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe RIA under the EU Cancer Mission supporting development of validated microbiome tools for early cancer prediction before disease onset, including AI risk modelling, longitudinal cohort studies, and comparison with liquid biopsy tests. Proposals must address multiple cancer types where possible and collaborate with large cohorts/registries. Lump sum grant; one grant expected.

Finances strategic advice by consulting professionals to prepare and conduct orientation and scientific advice meetings with regulatory authorities for planning and approval of clinical trials ('pre-IND meetings'). Focused on translation of medical/clinical projects.

Horizon Europe RIA (lump sum) for academic investigator-initiated pragmatic clinical trials on immunotherapeutic interventions for refractory cancer patients. Proposals must include a clinical studies annex, disaggregate data by sex/gender/age, and engage patients in endpoint definition. Applicants must include diverse stakeholders and plan to join the EU Cancer Mission 'Diagnosis and Treatment' cluster. ~3 grants expected.

Horizon Europe Coordination and Support Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €5M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Horizon Europe RIA under the Cancer Mission. Requires development of multiscale AI-integrated Virtual Human Twins for cancer onset, progression and personalised treatment. Proposals must include clinical study annex if clinical studies are envisaged. Interdisciplinary consortia including healthcare professionals, patient representatives, AI experts and SMEs expected. Open science principles mandatory; data must be shared via UNCAN.eu and Advanced VHT Platform.

Horizon Europe Innovation Action under the EU Cancer Mission call HORIZON-MISS-2026-02. One indicative grant of approximately €7M. Full topic description available in the Work Programme. Consortia must include eligible entities from at least 3 EU member states or associated countries.

Funds design and delivery of an EIT Label-certified Biotech pathway (personalised learning courses) within the Certified Innovation Path portfolio. Consortium must include ≥2 HEIs in ≥2 eligible Member States (at least one in an EIT RIS region) and ≥1 industry/non-academic partner. At least one HEI must be authorised to award ECTS credits. Focus on health biotech innovation, entrepreneurship, and translation to market-ready solutions across Europe.

Shaping the Future of Animal Health and Welfare — joint transnational call by the EUPAHW European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funder

Funding to develop an EIT Label-certified micro-credentials programme for advanced Master's students and PhD candidates in life sciences, medical technologies, and biotechnology. Programme must focus on entrepreneurship, innovation, and project management in healthcare. Open to EIT Health Members and Non-Members; applicants must register in the EU Funding & Tenders portal to obtain a PIC number before applying.

Open to European SMEs (≥4 FTE employees) in biotech, medtech, digital health, AI, and biomarkers/diagnostics. Must have raised ≥€2M equity in the prior 36 months with at least one new investor. Requires 50% co-funding from other sources. Innovation Maturity Level thresholds apply by sector (IML≥5 biotech, ≥6 medtech, ≥7 digital/diagnostics).

Consortium of min. 2 HEIs from 2 different eligible EU Member States (at least one in an EIT RIS region) plus at least one non-academic/industry partner. Funds design and delivery of EIT Label-certified personalised learning courses in health biotechnology for graduates and professionals across Europe.

Funds mature digital, data-driven and AI-powered healthcare solutions ready to scale across European markets. Covers commercialisation pilots, market adaptation, health economics analysis, and reimbursement pathway development. Applicants must be legal entities established in eligible Horizon Europe countries (EU Member States, associated countries, or eligible third countries); 50% co-funding required; SME-led consortia receive €400k–€500k within the grant.

Global Health EDCTP3 Calls for proposals 2026 — joint transnational call by the GH EDCTP3 JU European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating fu

RAMP Joint Transnational Call 2026 — joint transnational call by the Raw Materials for the Green and Digital Transition European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the cal

For postdocs with a PhD in a biological discipline moving to a new country and new research area. Must be ≤3 years post-PhD at Full Proposal deadline (24 Sep 2026). Applicants cannot work in their country of nationality or PhD country. For-profit host institutions ineligible. 100% FTE required. Basic life sciences research only; applied/clinical projects excluded.

For postdocs with a PhD in a non-biological discipline (physics, chemistry, mathematics, engineering, computer science) with no/little life sciences experience, moving to a new country. Must be ≤3 years post-PhD at Full Proposal deadline. Cannot work in country of nationality or PhD country. For-profit host institutions ineligible. 100% FTE required. Basic life sciences research only.

For applicants with a PhD in a biological discipline who want to pursue frontier, interdisciplinary life sciences research in a new country. Must change country, not work in country of nationality or PhD, and not have spent >12 months in host country. PhD conferred no earlier than 24 Sep 2023. 100% FTE commitment required. For-profit host institutions ineligible.

For applicants with a doctoral degree from a non-biological discipline (physics, chemistry, mathematics, engineering, computer sciences) with no or little life sciences experience, pursuing frontier interdisciplinary life sciences research in a new country. Must change country, not work in country of nationality or PhD, and not have spent >12 months in host country. PhD conferred no earlier than 24 Sep 2023. 100% FTE commitment required.

Annual call for cancer research projects with Nordic collaboration. Total budget €950,000. Applications submitted via NCU's own portal. Nordic cross-country collaboration is required.

Annual call for cancer research projects with Nordic collaboration. Norwegian Cancer Society contributes annually to this Nordic Cancer Union initiative. Information and application portal available on NCU's website. Questions to ncu@kreftforeningen.no.

Annual call for cancer research projects with Nordic collaboration, funded by Nordic Cancer Union with Norwegian Cancer Society contributions. Total budget €950,000. Information and application portal on NCU's website. Questions to ncu@kreftforeningen.no.

Annual call for cancer research projects with Nordic collaboration. Total pool of €950,000. Applications submitted via NCU's own portal. Questions to ncu@kreftforeningen.no.

PRIMA Call 2026 Section 2 — joint transnational call by the PRIMA European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

Boehringer Ingelheim Fonds MD Fellowship funds medical students (primarily enrolled in Germany) for an experimental basic-biomedical research project in a leading lab away from their home institution.

Bilateral project funding under the Weave procedure between SNSF (Switzerland) and GACR (Czech Republic). Applicants must be based at Swiss or Czech institutions. Max two simultaneous SNSF project grants allowed; one must be a Weave/Lead Agency project. Projects must start on the same date in both countries and run for the same duration (max 36 months).

Boehringer Ingelheim Fonds PhD Fellowship funds ambitious basic biomedical PhD projects. Europe-wide: EU citizens anywhere, or non-EU citizens whose PhD is at a European host. Experimental basic biomedical research only.

Directly funded by the European Union and fully managed by the PRIMA Foundation. Supports transnational research and innovation projects among Mediterranean countries. Focuses on water management, agricultural systems, and the agri-food chain (water-energy-food-ecosystems nexus). Consortium of partners from Mediterranean/EU countries required.

PRIMA Call 2026 Section 1 — joint transnational call by the PRIMA European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

CETP Joint Call 2026 — joint transnational call by the CETP European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

IHI Call 13 — joint transnational call by the Innovative Health Initiative European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

Achieving open strategic autonomy in digital and emerging en — joint transnational call by the Made in Europe European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for

Open to researchers of any nationality, 0–10 years post-PhD (extensions possible for parental leave, illness, etc.), proposing frontier research in any field. Host institution must be a public or private research organisation in an EU Member State or Horizon Europe associated country. Single PI applies; no consortium required.

Residential fellowships at the Gulbenkian Institute for Advanced Study (IGEA) for internationally renowned scholars, emeritus professors, independent academics, and artists. Open to most research domains without laboratory/experimental requirements; work must not be predominantly practical or applied. Applications submitted individually with CV, project description, and two referees.

NERC/UKRI call addressing ecosystem transitions for resilient economy and security. Applications submitted via UKRI Funding Service (not Je-S). Only the lead research organisation may submit. NERC marine facilities and BAS Antarctic logistics support require separate pre-approval processes. Proposals must address one of three stated research themes.

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

EIC call (HORIZON-EIC-2026-STEP-DEFENCE-01): HORIZON EIC Equity Only

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

ERDERA Clinical Trial Call 2026 (pre-announcement) — joint transnational call by the ERDERA European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating fun

Invite-only full application stage for NERC Large Grants. Applicants must be based at UK research organisations eligible for NERC funding. Associated studentships may be available. Proposals must align with NERC's environmental science remit.

Novel ecosystems: biodiversity, socio-ecological consequence — joint transnational call by the Biodiversa-plus European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page fo

Water4All 2025 Joint Transnational Call - Sustainable Water — joint transnational call by the Water4All European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for parti

Supports early-stage, pre-development concepts with potential to transform cancer immunotherapy; targets innovative technology approaches prior to full development.

Applicants must hold a tenure-track position at a not-for-profit research center or institution. Funds early-stage, pre-development cancer immunotherapy technologies (computational, profiling, visualization, culture systems, novel therapeutics). Does not support clinical trials or continuation of existing technologies. Proposals must be submitted in English via online portal.

DUT Call 2026 — joint transnational call by the DUT European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

M-ERA.NET Joint Call 2026 — joint transnational call by the M-ERA.NET 3 European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

MSCA Doctoral Networks fund collaborative doctoral training programmes across a consortium of academic and non-academic organisations. Doctoral candidates (early-stage researchers) must not have a PhD and must comply with MSCA mobility rules (not resided/worked in host country >12 months in last 3 years). Proposals submitted in English.

Supports innovative investigations at the intersection of laboratory discovery and clinical application in cancer immunology, accelerating translation of immunological discoveries into therapies.

Supports pioneering immunotherapy clinical trials designed and led by academic researchers; requires a clinical trial protocol concept at submission.

Open to tenure-track assistant professors or higher at non-profit medical schools and research centers worldwide (US or abroad); no citizenship restrictions; for-profit institutions ineligible. Funds translational cancer immunology research bridging lab discovery and clinical application, including a chordoma-focused track co-funded with the Chordoma Foundation. Renewal of up to $300k/2 years available in year 2 for exceptional projects.

Improved system design for innovative PV applications — joint transnational call by the EUPI-PV European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating

Funds investigator-initiated phase I/II or phase II immunotherapy clinical trials led by academic PIs. Open to researchers worldwide at medical schools or research centers; for-profit institutions are ineligible. No citizenship restrictions. Indirect costs up to 10% provided in addition to award. Partnership with Chordoma Foundation for chordoma-focused proposals.

Open to laboratories, organisations, or collaborative projects focused on fighting blindness and visual impairment, primarily in developing regions, and/or developing innovations/technologies for the visually impaired (odd-year focus). Candidates may span multiple disciplines or institutions. Award funds unrestricted (except commercial use); no individual researcher eligibility.

2027 cycle (odd year): recognises organisations fighting blindness and visual impairment primarily in developing regions and/or developing new technologies to assist the visually impaired. Eligible candidates include labs, organisations, or collaborative projects. Award unrestricted in use (except commercial purposes). Laureates announced each September.

Supports the transition of distinguished postdoctoral researchers into independent tenure-track investigators in cancer immunotherapy.

Supports mid-career scientists pursuing high-risk, high-reward research at the leading edge of cancer immunotherapy.

Branco Weiss Fellowship (Society in Science, administered by ETH Zurich) funds postdocs (PhD ≤5y, before first faculty post) pursuing independent, interdisciplinary research at any host institution worldwide. Not host-country-restricted.

For mid-career scientists (tenure-track assistant professors with ≥3 years in role, or associate professors with ≤3 years in role) with MD, PhD, or MD/PhD. Minimum 80% research time commitment. Open to US and international institutions; for-profit institutions ineligible. Funds high-risk, high-reward cancer immunotherapy research.

Supports excellent postdoctoral researchers; international mobility is a key requirement (applicant must move to a different country). Includes salary/stipend, relocation allowance, and childcare support. A first-author refereed preprint is considered equivalent to a first-author publication for eligibility. Host lab may support a maximum of one candidate per selection round.

Open to established researchers or teams led by an established researcher based at eligible not-for-profit organisations in the UK, Republic of Ireland, or low- and middle-income countries (excluding India and mainland China). Research must fit within Wellcome's Discovery Research remit and have potential to improve human life, health, and wellbeing across any discipline including STEM, humanities, social science, and public health.

Production technologies for solar photovoltaics beyond the s — joint transnational call by the EUPI-PV European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for partic

Open to life scientists who have been group leaders for less than 4 years at time of application. Provides financial support for networking, training opportunities, support for lab members, and mentoring over 4 years. Applicants must be setting up their laboratories.

MSCA call (HORIZON-MSCA-2027-COFUND-01): HORIZON TMA MSCA Cofund Doctoral programme

MSCA call (HORIZON-MSCA-2027-COFUND-02): HORIZON TMA MSCA Cofund Postdoctoral programme

MSCA call (HORIZON-MSCA-2027-SE-01): HORIZON TMA MSCA Staff Exchanges

Transnational call for international consortia of researchers and societal partners, part of Horizon Europe. SIA makes budget available per round for participation of Dutch hogescholen. Executed by the DUT partnership.

Supports group leaders establishing new laboratories in participating countries (2026 call: Croatia, Czechia, Estonia, Hungary, Lithuania, Luxembourg, Poland, Portugal, Türkiye) to strengthen life sciences there. Grantees join the EMBO Young Investigator/Installation Grantee international network.

MSCA call (HORIZON-MSCA-2027-CITIZENS-01): HORIZON Coordination and Support Actions

MSCA call (HORIZON-MSCA-2027-PF-01): HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

MSCA call (HORIZON-MSCA-2027-DN-01): HORIZON TMA MSCA Doctoral Networks

NCU grant supporting and encouraging cancer research collaboration between the Nordic countries. Applications close early September 2026. Promotes cross-Nordic partnerships in cancer research.

Supports high-risk, high-reward cancer research worldwide across basic research, therapeutic discovery, innovative technologies, and early-stage clinical trials. PIs must be independent researchers at their institutions. Indirect costs capped at 10% of direct costs. Applications by invitation or via RFPs; revenue sharing terms apply.

Open to researchers of any nationality with 2–7 years post-PhD experience (extensions possible for parental leave, illness, etc.). Host institution must be a public or private research organisation in an EU Member State or Horizon Europe associated country. Single PI applies; any field of research eligible. Proposals submitted via EU Funding & Tenders Portal.

Open to master's, doctoral, and postdoctoral researchers enrolled at internationally recognised universities, working on Armenian Studies (broadly defined). In 2026, priority given to contemporary/post-Soviet topics with policy relevance. Disciplines include political science, sociology, anthropology, law, human rights, diaspora/migration studies, and related fields. 7–10 grants expected; fixed annual amounts per call conditions document.

Long-Term Fellowships (LTF) and Cross-Disciplinary Fellowships (CDF) for postdoctoral researchers. Applicants must hold a PhD; fellowship must be undertaken in an HFSPO member country. Excludes primarily clinical, pharmaceutical, applied engineering/biotech, or agricultural projects. Preference for applicants adding new methods, study systems, or theory.

Open to researchers of any nationality with 5–15 years post-PhD experience (extendable for parental leave, illness, etc.). Host institution must be a public or private research organisation in an EU Member State or Horizon Europe associated country. Single PI applies; any field of research; bottom-up, no predetermined priorities.

Open to PhD holders with ≤8 years post-PhD research experience. European Fellowships: any nationality, host in EU/Associated Country, MSCA mobility rule (≤12 months in host country in prior 36 months). Global Fellowships: EU/Associated Country nationals or long-term residents only. Euratom areas: EU/Euratom Associated Country nationals only. All disciplines. Resubmission restrictions apply for scores below 80% from prior year.

Funds research on early intervention for cognitive and functional outcomes in people experiencing or at risk of psychosis. Open to HEIs, research institutes, non-academic healthcare orgs, NGOs, and companies worldwide (excluding mainland China and sanctioned countries). Lived experience involvement is mandatory. Lead applicant must contribute ≥20% research time. Phase III pharmacological trials and animal-model research are excluded.

Funds research into biological, psychological and/or social mechanisms by which causal factors lead to anxiety/trauma-related problems. Open to HEIs, research institutes, non-academic healthcare orgs, NGOs and commercial organisations globally. UK/Republic of Ireland-based lead applicants cannot claim their own salary. No funds for activities involving transfer of grant funds into mainland China.

Open to researchers at any career stage and discipline focused on anxiety and depression treatment. Host organisations include HEIs, research institutes, non-academic healthcare, NGOs, and companies worldwide (excluding mainland China). UK/ROI-based lead applicants cannot request their own salary. Lived experience involvement encouraged.

MSCA Doctoral Networks fund doctoral training programmes implemented by multi-country, inter-sectoral partnerships. Supports Industrial Doctorates (joint academic/non-academic supervision) and Joint Doctorates (leading to joint/double/multiple degrees). Open to organisations from third countries. Doctoral candidates recruited via open, transparent, merit-based selection. RAISE variant supports AI-in-science networks.

Funds international exchange programmes in health-related humanities, social sciences, or bioethics. Lead applicant must be UK-based; at least one co-applicant must be outside the UK (mainland China ineligible). All applicants require permanent/long-term contracts. High-income country organisations must demonstrate significant additional resource commitment. Salary recovery from grant funding permitted with ≥10% time commitment.

For group leaders in Croatia, Czech Republic, Estonia, Greece, Hungary, Italy, Lithuania, Luxembourg, Poland, Slovenia, or Turkey to visit scientists in other EMBC Member States to develop collaborative projects or prepare joint grant proposals.